EU OKs Dune's next-gen breast cancer tissue assessment device

02/20/2013 | Boston Herald

Dune Medical Devices has obtained approval in Europe to market a next-generation version of its MarginProbe System console, a device used for intra-operative tissue evaluation during early-stage breast cancer procedures. The MarginProbe System Type 1.2 improves on the original model with a more compact size, better aesthetics and enhanced overall design.

View Full Article in:

Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC